Pages that link to "Q44826001"
Jump to navigation
Jump to search
The following pages link to Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis (Q44826001):
Displaying 50 items.
- Systematic review and meta-analysis of randomised trials and cohort studies of mycophenolate mofetil in lupus nephritis (Q21195423) (← links)
- Treatment for lupus nephritis (Q24202572) (← links)
- Lupus Nephritis in Asia: Clinical Features and Management (Q26740487) (← links)
- Current and emerging treatment options in the management of lupus (Q26741266) (← links)
- Long-term data on corticosteroids and mycophenolate mofetil treatment in lupus nephritis. (Q30577281) (← links)
- Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient meta-analysis (Q33805412) (← links)
- Cyclophosphamide and lupus nephritis: when, how, for how long? (Q34095231) (← links)
- Population Pharmacokinetics of Mycophenolic Acid and Metabolites in Patients With Glomerulonephritis (Q34152549) (← links)
- Unexpected recovery from longterm renal failure in severe diffuse proliferative lupus nephritis (Q34367705) (← links)
- Belimumab for the treatment of systemic lupus erythematosus (Q34455827) (← links)
- Mycophenolate mofetil versus azathioprine as maintenance therapy for lupus nephritis: a meta-analysis (Q34462600) (← links)
- Efficacy of long-term maintenance therapy with mycophenolate mofetil in lupus nephritis (Q34490782) (← links)
- The emergence of mycophenolate mofetilin dermatology: from its roots in the world of organ transplantation to its versatile role in the dermatology treatment room (Q34536203) (← links)
- Mycophenolate mofetil as maintenance therapy for proliferative lupus nephritis: a long-term observational prospective study (Q34613945) (← links)
- Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis (Q34975939) (← links)
- Early change in proteinuria as a surrogate outcome in kidney disease progression: a systematic review of previous analyses and creation of a patient-level pooled dataset (Q35025425) (← links)
- Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease (Q35310520) (← links)
- Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies (Q35456519) (← links)
- Efficacy, pharmacokinetic and pharmacodynamic profile of belimumab for systemic lupus erythematosus (Q35761089) (← links)
- Induction of remission in active anti-neutrophil cytoplasmic antibody-associated vasculitis with mycophenolate mofetil in patients who cannot be treated with cyclophosphamide (Q35953330) (← links)
- Outcome of low dose cyclophosphamide for induction phase treatment of lupus nephritis, a single center study (Q36157955) (← links)
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis (Q36221407) (← links)
- Clinicopathological findings, treatment response and predictors of long-term outcome in a cohort of lupus nephritis patients managed according to the Euro-lupus regime: a retrospective analysis in Sri Lanka (Q36266807) (← links)
- Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis (Q36302245) (← links)
- Basic immunosuppressive drugs outside solid organ transplantation (Q36407314) (← links)
- Contemporary treatment of systemic lupus erythematosus: an update for clinicians. (Q36443689) (← links)
- Mycophenylate mofetil: what role in the treatment of lupus? (Q36458168) (← links)
- Update on the treatment of lupus nephritis (Q36575376) (← links)
- Optimum therapeutic approaches for lupus nephritis: what therapy and for whom? (Q36577362) (← links)
- Systemic lupus erythematosus--2005 annus mirabilis? (Q36577432) (← links)
- Emerging drug therapies for systemic lupus erythematosus (Q36634248) (← links)
- Value of a complete or partial remission in severe lupus nephritis (Q36666936) (← links)
- Thirty years of cyclophosphamide: assessing the evidence (Q36790803) (← links)
- Current management of lupus nephritis: popular misconceptions (Q36790809) (← links)
- Adverse event burden, resource use, and costs associated with immunosuppressant medications for the treatment of systemic lupus erythematosus: a systematic literature review (Q36802101) (← links)
- The frequency and outcome of lupus nephritis: results from an international inception cohort study (Q37082037) (← links)
- A Protocol for the Pharmacokinetics of Enteric Coated Mycophenolate Sodium in Lupus Nephritis (POEMSLUN): an open-label, randomised controlled trial (Q37086991) (← links)
- Current treatment of lupus nephritis (Q37168027) (← links)
- Mediators of inflammation and their effect on resident renal cells: implications in lupus nephritis (Q37221965) (← links)
- Update on the management of lupus nephritis: let the treatment fit the patient (Q37255744) (← links)
- Treatment options for proliferative lupus nephritis: an update of clinical trial evidence (Q37288728) (← links)
- Mycophenolate mofetil in the treatment of lupus nephritis. (Q37290624) (← links)
- An update on the use of mycophenolate mofetil in lupus nephritis and other primary glomerular diseases (Q37378976) (← links)
- Oral cyclophosphamide for lupus glomerulonephritis: an underused therapeutic option (Q37415711) (← links)
- Influence of race/ethnicity on response to lupus nephritis treatment: the ALMS study (Q37462538) (← links)
- Pharmacotherapy of systemic lupus erythematosus. (Q37510905) (← links)
- Induction and maintenance therapy for lupus nephritis: a systematic review and meta-analysis (Q37671987) (← links)
- Review: Lupus nephritis: pathologic features, epidemiology and a guide to therapeutic decisions. (Q37678723) (← links)
- Update on emerging drug therapies for systemic lupus erythematosus (Q37690745) (← links)
- Novel approaches to therapy for systemic lupus erythematosus: update 2005. (Q37754557) (← links)